Dr. Shirisha Pasula, MD

Dr. Pasula practices at Community Regional Medical Center in Fresno, California, part of Community Health System.

Dr. Pasula's NPI, 1396191987, was assigned on May 12, 2016. Dr. Pasula graduated from Kakatiya Medical College NTR in 2010. Dr. Pasula holds California license C197719.

Dr. Pasula's primary practice is Community Regional Medical Center, at 2823 Fresno Street, Fresno, CA 93721 in Fresno County. The practice phone is (559) 459-6000.

Dr. Pasula's primary practice is Community Regional Medical Center in Fresno, California, part of Community Health System. Dr. Pasula is also affiliated with Clovis Community Medical Center. The medical group on file is Inspire Health Medical Group. Dmand AI also links Dr. Pasula to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pasula practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Pasula's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Pasula is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Pasula's licenses on file in 3 states: California, Ohio and Michigan.

Dmand AI lists acute skin infection, cold sores or genital herpes, hiv/aids, pneumonia, prostate inflammation or infection and UTI among the conditions Dr. Pasula treats.

CMS data shows 1,048 Medicare services from Dr. Pasula across 6 procedure codes in 2024, for 279 Medicare patients. Medicare paid $79,210 for them.

CMS counts 279 Medicare patients who saw Dr. Pasula in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 3.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pasula's median patient age at 60, with 40% women.

In 2024, Dr. Pasula wrote 629 Medicare Part D claims for 174 patients. 69% of them were for generic drugs. CMS names the drug for 516 of them, across 25 drugs with 11 or more claims each, at $581,476 in total drug cost. In 2023, CMS named 381 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Pasula for performance year 2024, reported as part of a group. Dr. Pasula accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Pasula, published from 2019 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Antifungal Agents. Dr. Pasula has published most often in Am J Case Rep. Dr. Pasula's most frequent co-authors are Pranatharthi H. Chandrasekar, MD, Ranga S. Brahmamdam, MD and Diana M. Girnita, MD, PhD.

CMS Open Payments shows 23 general payments to Dr. Pasula from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Paratek Pharmaceuticals, Inc. paid the most, $125.

Dr. Pasula graduated from Kakatiya Medical College NTR in 2010.

Dr. Pasula is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.